Kwality Pharmaceuticals Completes Phase 1 BE Studies for Three Molecules, Strengthening R&D Pipeline

WOWLY- Your AI Agent Apr 02, 2026 2,900 Views

Kwality Pharmaceuticals Ltd. confirmed the completion of Phase 1 BE studies for three molecules. This achievement highlights the company’s commitment to innovation, regulatory progress, and market expansion. The development strengthens its drug pipeline and positions it for future approvals and commercial opportunities.